Markets are Closed
AMGN
Amgen Inc.
Open
243.58
Previous Open
—
High
243.62
Previous High
—
Low
238.57
Previous Low
—
Close
240.69
Previous Close
—
Volume
1,363,466
Previous Volume
—
Company Profile
Description
Amgen Inc is a U.S. based biotechnology company, with historical expertise in renal disease and cancer supportive care products. The firm discovers, develops, manufactures and delivers human therapeutics.
Exchange
Nasdaq Global Select
List Date
January 02, 1990
CEO
Robert A. Bradway
Employees
20,800
Related Stocks
Financials
Revenue
23.36B
Earnings
10.42B
26B
21B
17B
12B
8B
2015
2016
2017
2018
Splits
| November 22, 1999 | 0.50% |
| March 01, 1999 | 0.50% |
Dividends
| June 08, 2020 | $1.60 |
| March 06, 2020 | $1.60 |
| December 06, 2019 | $1.45 |
| September 06, 2019 | $1.45 |
| June 07, 2019 | $1.45 |
| March 08, 2019 | $1.45 |
| December 07, 2018 | $1.32 |
| September 07, 2018 | $1.32 |
| June 08, 2018 | $1.32 |
| March 08, 2018 | $1.32 |
| December 08, 2017 | $1.15 |
| September 08, 2017 | $1.15 |
| June 08, 2017 | $1.15 |
| March 08, 2017 | $1.15 |
| December 08, 2016 | $1.00 |
| September 08, 2016 | $1.00 |
| June 08, 2016 | $1.00 |
| March 08, 2016 | $1.00 |
| December 07, 2015 | $0.79 |
| September 08, 2015 | $0.79 |
| June 05, 2015 | $0.79 |
| March 06, 2015 | $0.79 |
| December 05, 2014 | $0.61 |
| September 05, 2014 | $0.61 |
| June 06, 2014 | $0.61 |
| March 07, 2014 | $0.61 |
| December 06, 2013 | $0.47 |
| September 06, 2013 | $0.47 |
| June 07, 2013 | $0.47 |
| March 07, 2013 | $0.47 |
| December 07, 2012 | $0.36 |
| September 07, 2012 | $0.36 |
| June 07, 2012 | $0.36 |
| March 07, 2012 | $0.36 |
| December 08, 2011 | $0.28 |
| September 08, 2011 | $0.28 |
Related News
Amgen Stock Rises 3%
Mar 26, 2020 @ 11:38
Investing.com - Amgen (NASDAQ:AMGN) Stock rose by 3.10% to trade at $199.11 by 11:36 (15:36 GMT) on Thursday on the NASDAQ exchange....
finance yahooAmgen Stock Falls 3%
Mar 25, 2020 @ 09:32
Investing.com - Amgen (NASDAQ:AMGN) Stock fell by 3.17% to trade at $196.00 by 09:31 (13:31 GMT) on Wednesday on the NASDAQ exchange....
finance yahoo
Amgen to donate up to $12.5M to COVID-19 relief efforts
Mar 23, 2020 @ 21:25
Biotech company Amgen is committing $12.5 million to support relief efforts to address needs in communities impacted by the COVID-19 pandemic....
finance yahoo
Amgen And The Amgen Foundation Commit Up To $12.5 Million To Support COVID-19 Relief Efforts
Mar 23, 2020 @ 20:01
Amgen (NASDAQ:AMGN) and the Amgen Foundation today announced an initial commitment of up to $12.5 million to support U.S. and global relief efforts to address critical needs in communities impacted by the COVID-19 pandemic. The funds will be used to support emergency response efforts in Amgen's U.S...
finance yahoo
Despite Its High P/E Ratio, Is Amgen Inc. (NASDAQ:AMGN) Still Undervalued?
Mar 18, 2020 @ 10:35
The goal of this article is to teach you how to use price to earnings ratios (P/E ratios). We'll apply a basic P/E......
finance yahooAmgen Stock Rises 5%
Mar 13, 2020 @ 09:31
Investing.com - Amgen (NASDAQ:AMGN) Stock rose by 4.90% to trade at $191.00 by 09:30 (13:30 GMT) on Friday on the NASDAQ exchange....
finance yahoo
Hedge Funds Started Snapping Up Amgen, Inc. (AMGN) Too Early
Mar 12, 2020 @ 02:11
Coronavirus is probably the 1 concern in investors’ minds right now. It should be. On February 27th we publish an article with the title "Recession is Imminent: We Need A Travel Ban NOW". We predicted that a US recession is imminent and US stocks will go down by at least 20% in the next 3-6...
finance yahoo
Is Amgen (AMGN) Truly One of the Best Biotech Stocks to Own?
Mar 09, 2020 @ 14:19
Amgen (AMGN) boasts a strong biosimilars portfolio, which can drive long-term growth. Amgen is also progressing with its pipeline while regularly pursuing business development deals....
finance yahoo
Quest Diagnostics launching coronavirus test
Mar 05, 2020 @ 19:47
Quest Diagnostics announced it will begin screening for the coronavirus. Yahoo Finance’s Anjalee Khemlani joins Seana Smith on The Ticker to discuss....
finance yahoo
J&J Files Application for Darzalex Label Expansion With FDA
Feb 11, 2020 @ 14:15
J&J (JNJ) seeks approval for new Darzalex combo regimen in the United States to treat relapsed/refractory multiple myeloma patients who have received one to three prior lines of therapy....
finance yahoo